Deutsch English Français

Contact

EP1569618

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1569618

EP1569618 - METHODS AND COMPOSITIONS FOR APPLYING PHARMACOLOGIC AGENTS TO THE EAR [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 26.04.2019 Database last updated on 16.11.2024
Former	Grant of patent is intended Status updated on 12.07.2018
Former	Examination is in progress Status updated on 13.06.2018
Former	Grant of patent is intended Status updated on 01.03.2018
Former	Examination is in progress Status updated on 21.11.2016
Most recent event Tooltip	26.04.2019	Application deemed to be withdrawn	published on 29.05.2019 [2019/22]
Applicant(s)	For all designated states Regents of the University of Minnesota 450 McNamara Alumni Center 200 Oak Street S.E. Minneapolis, MN 55455-2070 / US
	[2018/13]
Former [2005/36]	For all designated states REGENTS OF THE UNIVERSITY OF MINNESOTA 450 McNamara Alumni Center, 200 Oak Street SE Minneapolis Minnesota 55455-2070 / US
Inventor(s)	01 / SAWCHUK, Ronald, J. 1762 - 20th Avenue N.W. New Brighton, MN 55112 / US
	02 / CHEUNG, Belinda, W., Y. 2531 Wexford Court New Brighton, MN 55112 / US
	[2005/36]
Representative(s)	Leonard, Thomas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB
	[N/P]
Former [2005/36]	Bassil, Nicholas Charles, et al Kilburn & Strode 20 Red Lion Street London WC1R 4PJ / GB
Application number, filing date	03796467.3	25.11.2003
	[2005/36]
	WO2003US37819
Priority number, date	US20020306517	27.11.2002 Original published format: US 306517
	[2005/36]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2004050021
	Date:	17.06.2004
	Language:	EN
	[2004/25]
	Type:	A2 Application without search report
	No.:	EP1569618
	Date:	07.09.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 17.06.2004 takes the place of the publication of the European patent application.
	[2005/36]
Search report(s)	International search report - published on:	US	29.07.2004
	(Supplementary) European search report - dispatched on:	EP	30.11.2009
Classification	IPC:	A61K31/43, A61K31/545, A61K31/546, A61K31/7048, A61K31/716, A61K31/4402, A61K31/5386, A61K31/5415, A61K9/06, A61K47/34, A61K9/00	[2018/07]
	CPC:	A61K9/0046 (EP,US); A61K31/43 (EP,US); A61K31/4402 (EP,US); A61K31/5386 (EP,US); A61K31/5415 (EP,US); A61K31/545 (EP,US); (+) A61K31/546 (EP,US); A61K31/7048 (EP,US); A61K31/716 (EP,US); A61K47/34 (EP,US); A61K9/06 (EP,US); A61P23/02 (EP); A61P27/16 (EP); A61P29/00 (EP); A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP); A61P43/00 (EP) (-)
	C-Set:	A61K31/43, A61K2300/00 (EP,US); A61K31/545, A61K2300/00 (US,EP); A61K31/546, A61K2300/00 (US,EP); A61K31/7048, A61K2300/00 (US,EP); (+) A61K31/716, A61K2300/00 (EP,US) (-)
	Former IPC [2005/36]	A61K9/14
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/36]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	VERFAHREN UND ZUSAMMENSETZUNGEN FÜR DIE VERABREICHUNG VON PHARMAKOLOGISCHEN MITTELN AN DAS OHR	[2005/36]
	English:	METHODS AND COMPOSITIONS FOR APPLYING PHARMACOLOGIC AGENTS TO THE EAR	[2005/36]
	French:	PROCEDES ET COMPOSITIONS PERMETTANT D'APPLIQUER DES AGENTS PHARMACOLOGIQUES DANS L'OREILLE	[2018/07]
	Former [2005/36]	PROCEDES ET COMPOSITIONS PERMETTANT D'APPLIQUER DES AGENTS PHARMACOLOGIQUES SUR L'OREILLE
Entry into regional phase	23.06.2005	National basic fee paid
	23.06.2005	Search fee paid
	23.06.2005	Designation fee(s) paid
	23.06.2005	Examination fee paid
Examination procedure	23.06.2005	Amendment by applicant (claims and/or description)
	23.06.2005	Examination requested [2005/36]
	07.09.2010	Despatch of a communication from the examining division (Time limit: M06)
	09.03.2011	Reply to a communication from the examining division
	06.03.2013	Despatch of a communication from the examining division (Time limit: M06)
	16.09.2013	Reply to a communication from the examining division
	01.02.2016	Cancellation of oral proceeding that was planned for 04.02.2016
	01.02.2016	Observations by third parties
	04.02.2016	Date of oral proceedings (cancelled)
	16.02.2016	Despatch of a communication from the examining division (Time limit: M06)
	26.08.2016	Reply to a communication from the examining division
	24.10.2016	Observations by third parties
	10.11.2016	Despatch of a communication from the examining division (Time limit: M04)
	20.03.2017	Reply to a communication from the examining division
	21.06.2017	Despatch of a communication from the examining division (Time limit: M04)
	01.11.2017	Reply to a communication from the examining division
	02.03.2018	Communication of intention to grant the patent
	11.06.2018	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	13.07.2018	Communication of intention to grant the patent
	24.11.2018	Application deemed to be withdrawn, date of legal effect [2019/22]
	10.01.2019	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2019/22]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.09.2010
Fees paid	Renewal fee
	29.11.2005	Renewal fee patent year 03
	27.11.2006	Renewal fee patent year 04
	27.11.2007	Renewal fee patent year 05
	25.11.2008	Renewal fee patent year 06
	25.11.2009	Renewal fee patent year 07
	24.11.2010	Renewal fee patent year 08
	23.11.2011	Renewal fee patent year 09
	26.11.2012	Renewal fee patent year 10
	27.11.2013	Renewal fee patent year 11
	26.11.2014	Renewal fee patent year 12
	30.11.2015	Renewal fee patent year 13
	28.11.2016	Renewal fee patent year 14
	27.11.2017	Renewal fee patent year 15
	27.11.2018	Renewal fee patent year 16
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]DE1138890 (MUNDIPHARMA AG) [X] 1,24,25,27 * column 3, lines 58-64 * * example 1 *;
		[X]EP0733357 (DOMPE SPA [IT]) [X] 1,12,24,25,27 * page 3, lines 1-17 * * example - *;
		[A]WO0018386 (ALCON LAB INC [US], et al) [A] 1-31 * abstract * * page 3, lines 14-19 * * page 7, lines 15-18 ** page 10, lines 1-15 *
	International search	[Y]US5057502 (WALSH WILLIAM E [US]);
		[Y]US5290552 (SIERRA DAVID H [US], et al);
		[A]US6093417 (PETRUS EDWARD J [US]);
		[A]US6027744 (VACANTI CHARLES A [US], et al)
	Examination	US4188373
		US4478822
		EP0694310
		- DEVI D R ET AL, "Poloxamer: A novel functional molecule for drug delivery and gene therapy", JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH 2013 PHARMAINFO PUBLICATIONS IND, (201308), vol. 5, no. 8, ISSN 0975-1459, pages 159 - 165
	by applicant	US6201072
	other	US4188373
		US4478822
		EP0694310
		WO0018386
		- DEVI et al., "poloxamer: a novel functional molecule for drug delivery and gene therapy", J. Pharm. Sci. & Res., (20130000), vol. 5, no. 8, pages 159 - 165, XP055255477
		- coles, sj et al, "a comparative study of clarithromycin and amoxicillin suspensions in the treatment of pediatric patients with acute otitis media", infection, vol. 21, no. 4, (19930000), XP055265649
		- Uhde G., "The Problem of Permeability and Anesthesia of the Tympanic Membrane", A. M. A. ARCHIVES OF OTOLARYNGOLOGY, vol. 66, (19571000), pages 391 - 407, XP055318372 DOI: http://dx.doi.org/10.1001/archotol.1957.03830280021004

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p